Two Part Study to Assess Comparative Bioavailability, Pharmacokinetics of a Single Dose of ACM-001.1, Two Single Doses of Pindolol (Part1) Followed by Evaluation of Steady State Pharmacokinetics, Pharmacodynamics of ACM-001.1 in HV (Part2)
Latest Information Update: 19 Dec 2024
At a glance
- Drugs Espindolol (Primary) ; Pindolol
- Indications Cachexia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Actimed Therapeutics
Most Recent Events
- 13 Dec 2024 According to an Actimed Therapeutics media release, results from this study have been published in The Journal of Cachexia, Sarcopenia and Muscle.
- 13 Dec 2024 Results presented in the Actimed Therapeutics Media Release.
- 04 Jan 2023 According to an Actimed Therapeutics media release, Status changed has been changed to completed.